Nature's Sunshine Products (NASDAQ:NATR) Given "Hold (C)" Rating at Weiss Ratings

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report)'s stock had its "hold (c)" rating reiterated by investment analysts at Weiss Ratings in a report issued on Saturday,Weiss Ratings reports.

A number of other research analysts have also commented on NATR. Canaccord Genuity Group raised their price target on Nature's Sunshine Products from $21.00 to $22.00 and gave the company a "buy" rating in a report on Friday, August 1st. DA Davidson set a $21.00 price target on Nature's Sunshine Products in a report on Tuesday. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, Nature's Sunshine Products currently has an average rating of "Moderate Buy" and a consensus price target of $21.50.

Nature's Sunshine Products Stock Down 0.4%

Shares of Nature's Sunshine Products stock opened at $14.10 on Friday. The company has a 50 day moving average of $15.95 and a 200 day moving average of $14.85. The company has a market capitalization of $248.72 million, a P/E ratio of 19.05 and a beta of 1.12. Nature's Sunshine Products has a 52-week low of $11.01 and a 52-week high of $18.06.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $0.35 EPS for the quarter, topping the consensus estimate of $0.16 by $0.19. The business had revenue of $114.75 million for the quarter, compared to analyst estimates of $113.10 million. Nature's Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%. Nature's Sunshine Products has set its FY 2025 guidance at EPS.

Insiders Place Their Bets

In other news, EVP Nathan G. Brower sold 9,996 shares of Nature's Sunshine Products stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $16.54, for a total transaction of $165,333.84. Following the completion of the transaction, the executive vice president directly owned 48,277 shares in the company, valued at approximately $798,501.58. The trade was a 17.15% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Bryant J. Yates sold 5,000 shares of the business's stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $16.77, for a total value of $83,850.00. Following the completion of the sale, the executive vice president owned 102,170 shares of the company's stock, valued at $1,713,390.90. This trade represents a 4.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 24,668 shares of company stock valued at $409,803 in the last 90 days. 4.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of NATR. Janney Montgomery Scott LLC bought a new stake in Nature's Sunshine Products during the first quarter worth $340,000. Russell Investments Group Ltd. lifted its stake in Nature's Sunshine Products by 351.2% during the first quarter. Russell Investments Group Ltd. now owns 12,398 shares of the company's stock worth $156,000 after purchasing an additional 9,650 shares during the last quarter. Nuveen LLC bought a new position in Nature's Sunshine Products in the 1st quarter valued at approximately $437,000. Strs Ohio bought a new position in Nature's Sunshine Products in the 1st quarter valued at approximately $375,000. Finally, Skylands Capital LLC lifted its position in Nature's Sunshine Products by 1.7% in the 1st quarter. Skylands Capital LLC now owns 431,800 shares of the company's stock valued at $5,419,000 after acquiring an additional 7,209 shares in the last quarter. Institutional investors own 79.40% of the company's stock.

Nature's Sunshine Products Company Profile

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.